1/39
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
---|
No study sessions yet.
Heritable genetic diseases
mutations are present in the germline
Numerical chromosome abnormalities
polyploidy - an extra set of chromosomes
aneuploidy - an extra or missing single chromosome
How do numerical chromosome abnormalities occur?
occur during cell division in the female germline
chromosomes line up during meiosis
kinetochore won’t properly attach so both chromosomes are brought ot one side
nondisjunction occurs
other cell is unviable
Splice sight mutations
mutation in the splice acceptor site
affects the efficiency at which the spliceosome recognises that site
extension of TT or GT repeats
this results in an exon skipping resulting in wrong mRNA
Dominant mutations
one copy is sufficient for a given disease phenotype
can occur via haploinsufficiency
Dominant negative effect
one copy is normal but the mutated copy interferes with the function of th enormal protein
occurs in osteogenesis imperfecto
collagen gene mutations
normally form fibres
mutations interfere with the way collagen fibres pack leading to brittle bones
Mendelian Inheritance
the presence of mutation in a single gene is sufficient for disease manifestation
a single gene is responsible for one phenotype
Locus Heterogeneity
deviation from Mendelian Inheritance
one phenotype can be caused by mutations in any one of a number of genes
Outcomes of Locus Heterogeneity
hearing loss
because mutations occur in two different genes, children always inherit one normal gene - phenotypic rescue
Incomplete penetrance
observed in dominant modes of inheritance
the mutation is or should be present but it is not leading to the disease (even though it should since it is dominant)
although these mutations should cause disease, there are other factors that influence (genetic background, environment) whether the disease is manifested or not
X mosaicism
males have one X and one Y chromosome
females have two but that is two many
one of the X chromosome is inactivated - random (around 200 cell stage embryo)
randomness can lead to deviations in whats expected from Mendelian patter
embryos have the same heterozygous state
manifesting heterozygote - shouldn’t normally express the disorder but because of x inactivation it does
Mitochondrial Inheritance
inheritance is matrolineal
mitochondria are only inherited from mother
sperm delivers its nuclear genetical material but the mitochondria remain behind
mitochondria don’t enter the egg cell
Heteroplasmy effect
cells have different ratios of the mutated mitochondria
small amount of mitochondrial go into each early egg precursor
widely differing ratios of mutated mitochondria in fully develop egg cells
due to bottleneck effect we get different ratios
results in siblings having differing severities of the disease
because process is random, it is difficult to predict ratios in mitochondrial diseases
another effect is that it can lead to different ratios of mutated mitochondria in different organ and tissue types
they have different thresholds (e.g some have a low threshold - smaller amount of mitochondria to cause an adverse phenotype)
high energy use tissues and organs will be the most frequently affected
brain and skeletal muscle have low phenotypic expression
Complex traits
several genes contribute in an additive fashion to determine an end phenotypic outcome
Mendel studies focused on binary traits (exist in one form or another)
for most traits we observe a continuous distribution
The polygenic/infinitesimal model
additive to the phenotypic outcome
each allele has a smaller effect but you need to inherit several to manifest the disease
Polygenic threshold model
account for the fact that the disease is either expressed or not
it is only when a certain disease threshold hold is breached that the disease is manifest
The Carter effect
some complex genetic diseases also display sex dimorphism, an explanation for these might be provided by polygenic threshold model
when females do present within the family, there is a higher number of risk alleles within that family
Heritability
population specific parameter
the phenotypic variation in a given population that is due to variation in genetic factors within the population
Estimation of heritability
determined by twin studies
monozygotic twins which you can pair with dizygotic twins
compare rates of phenotypic correlation for a certain cancer
dizygotic provide a good control for the environment
if high correlation from mono - high contribution from genetic factors
correlation in mono never reaches 100%
tells us that environment plays a significant role
Liability Threshold model
incorporates environmental factors
genetic and environmental factors can contribute to complex disease manifestations
Heritability = Vg / Vp
Estimates from twin studies according to Falconer’s Formula
Heritability (broad sense) = 2(CR mz - CR dz)
Interactions between genetic variants in broad sense heritability
Dominance Interaction - interaction within a locus
Epistasis - interaction between loci
one variant can influence whether one variant is phenotypically expressed
Somatic mutations in non cancerous disease
understanding is poor as they are difficult to detect because there are in small amounts
modern sequencing approaches have helped sequencing
we can predict the earlier the mutation occurs the more likely it will have an adverse phenotypic effect
location dependent
mental health is influenced by somatic mutations
mutations we pick up along the way can influence our phenotypic expression
Key features of cancerous cells
the ability to replicate indefinitely
the ability to evade apoptosis
Examples of early drivers of cancers
Mutations that inactivate DNA repair pathways
mutations that increase the rate of cell divisions and therefore DNA replication
Cancer stem cells
can replicate themselves or differentiate into a different tissue type
naturally hardwired into them is disability one of the hallmarks of a cancer cell
if they undergo a mutation, it will accelerate the mutation rate it is then referred to as a cancer stem cell
has the ability to self renew indefinitely naturally
picks up a mutation that confers other basic cancer property
How to target cancer stem cells
chemotherapeutic agent that has cytotoxic effect kills the tumour cells but not the cancer cell
because the ability to replicate indefinitely
repopulation of tumour
target cancer cell to prevent tumour from reforming
Oncogenes
genes that become activated in some way and drive tumour formation
only one copy of the gene needs ot be mutated (dominant mutation)
usually occur in cases with no family history (sporadic)
The philadelphia chromosome and Leukaemia
translocation netween chromosome 9 and 22
break points are lcoated within two important genes
chromosome 9 - able gene, chromosome 22 - bcr gene
after translocation is philadelphia chromosome that contains a fusion of the abl and bcr gene
ABL gene
regulates haematopoietic cell division
turn on in which it will promote the proliferation in the haematopoietic compartment
How does Abl and BCR fusion impact Abl
locks Abl activity into on position - uncontrolled proliferation within the haematopoietic cell compartment leading to promotion of tumour creation
MYCN amplification and neuroblastoma
within gene promoters where a gene is amplified
Macan gene amplified leading to cancer
function: transcription factor binding to heterodimer interacting with Max (TF)
binds to E box driving transcription of neural pre cursor cells
turns on genes that will drive the proliferation iwhtin this neural precursor compartment
when amplifed: over activation of E box and over production of genes, over proliferation - tumours
occurs in neural crest compartment
go on to form sympathetic nervous system e.g neuroblastoma
Tumour supressor genes
dont undergo any gain of function mutation
inactivated by mutation
display a family history and not sporadic
need to occur in both copies of the gene
Knudsons two hit hypothesis
tumour formation in the retina
in you inherit one copy that is going to be present in all cells of the offspring
you only need to inactivate one copy in any one of those cells, which is more likely than having to inherit two copies
cancer is quite unlikely
Breast cancer and Fanconi’s anaemia
if you inherit one copy your risk jumps a lot
genes play a role in DNA damage repair
How do BRCA1 and BRCA2 play a role in DNA damage repair?
repair double strand breaks: a bit of the DNA goes missing e.g ionizing radiation
BRCA 1 senses break and recruits a BRCA2 RAD51 complex
NON HOMOLGOUS INJOINING
stitch back together two chromosomal ends, error prone
HOMOLOGOUS
error free recombination
resection of one of the stands of these chromosomal ends
enzymes come along and digesting away one of the strands on both broken chromosomal ends
those generated single stranded regions will search cell for sequence homology
polymerase comes along and uses that SS region as a primer and extends
Fanconi’s anaemia
congenital condition associated with bone marrow failure, developmental abnormalities present at birth and increased risk of leukaemia
biallelic mutations in any one of several genes can cause FA
biallelic mutations in BRCA2 can also cause FA
mutations can occur in different timeframes which can lead to one of the two diseases to occur (Breast cancer or FA)
Difference in phenotypes of Breast Cancer and FA
BREAST CANCER
inherit one normal copy of BRCA2 and one defected copy
both copies need to be inactivated - normal phenotype
only when second copy is inactivated that leads to defective
FA
both copies are inherited
present from single cell zygote stage
present during embryonic development
symptoms observed from birth
Von Hippel-Lindau Syndrome
mutation in Von Hippal Lindau gene
two copies leads to tumours occuring on vasculatur
with one copy you still get these other phenotype (vision impairments, poor motor skills)
VHL pathway defect
NORMAL
VHL protein forms an interation with HIF alpha
HIF alpha is a protein involved in transcription
VHL usually binds to it and tags it with ubiquitin (degradation)
HYPOXIC
VHL modified and nitrosilated and can no longer bind
free to interact with another TF and forms a hetero dimer and interacts with promoters to activate expression of certain growth genes
e.g vascular endothelial growth factor of EGF driving proliferation and angiogenesis
it occurs constituvely with no regulation in blood vessel precursor cell - high potential of tumour formation